These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
55 related items for PubMed ID: 1776855
1. The effect of doxorubicin, daunorubicin and 4'-epidoxorubicin on the exogenous c-myc promoter in mouse erythroleukemia cells. Eliopoulos A, Kerr DJ, Spandidos DA. Anticancer Res; 1991; 11(6):2153-7. PubMed ID: 1776855 [Abstract] [Full Text] [Related]
2. The effect of cisplatin and carboplatin on c-myc promoter in erythroleukemic cells. Eliopoulos A, Kerr DJ, Spandidos DA. Anticancer Drugs; 1991 Dec; 2(6):597-601. PubMed ID: 1806037 [Abstract] [Full Text] [Related]
3. Induction of the c-myc but not the cH-ras promoter by platinum compounds. Eliopoulos AG, Kerr DJ, Maurer HR, Hilgard P, Spandidos DA. Biochem Pharmacol; 1995 Jun 29; 50(1):33-8. PubMed ID: 7605342 [Abstract] [Full Text] [Related]
4. Cis-platin responsive sequences in the human c-myc promoter. Spandidos DA, Zoumpourlis V, Lang JC. Anticancer Res; 1991 Jun 29; 11(3):1339-42. PubMed ID: 1888169 [Abstract] [Full Text] [Related]
8. Induction of cell death in murine fibroblasts by a c-myc promoter binding protein. Ray RB. Cell Growth Differ; 1995 Sep 29; 6(9):1089-96. PubMed ID: 8519685 [Abstract] [Full Text] [Related]
9. Transfer of human globin genes to human erythroleukemia cells. Spandidos DA. Mol Biol Med; 1984 Jun 29; 2(3):167-75. PubMed ID: 6100386 [Abstract] [Full Text] [Related]
10. Epidoxoform: a hydrolytically more stable anthracycline-formaldehyde conjugate toxic to resistant tumor cells. Taatjes DJ, Fenick DJ, Koch TH. J Med Chem; 1998 Apr 09; 41(8):1306-14. PubMed ID: 9548820 [Abstract] [Full Text] [Related]
11. The carbonic anhydrase I locus contains a c-Myb target promoter and modulates differentiation of murine erythroleukemia cells. Chen J, Kremer CS, Bender TP. Oncogene; 2006 May 04; 25(19):2758-72. PubMed ID: 16407849 [Abstract] [Full Text] [Related]
12. Regulation of Xenopus c-myc promoter activity in oocytes and embryos. Modak SP, Principaud E, Spohr G. Oncogene; 1993 Mar 04; 8(3):645-54. PubMed ID: 8437848 [Abstract] [Full Text] [Related]
13. Modulation of cis-platinum resistance in Friend erythroleukemia cells by c-myc. Sklar MD, Prochownik EV. Cancer Res; 1991 Apr 15; 51(8):2118-23. PubMed ID: 2009531 [Abstract] [Full Text] [Related]
14. Identification of a PDGF-responsive element in the murine c-myc gene. Sacca R, Cochran BH. Oncogene; 1990 Oct 15; 5(10):1499-505. PubMed ID: 2250909 [Abstract] [Full Text] [Related]
15. DNA topoisomerase II inhibitor, etoposide, induces p21WAF1/CIP1 through down-regulation of c-Myc in K562 cells. Horiguchi-Yamada J, Fukumi S, Saito S, Nakayama R, Iwase S, Yamada H. Anticancer Res; 2002 Oct 15; 22(6C):3827-32. PubMed ID: 12553001 [Abstract] [Full Text] [Related]
16. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells. Slapak CA, Fracasso PM, Martell RL, Toppmeyer DL, Lecerf JM, Levy SB. Cancer Res; 1994 Nov 01; 54(21):5607-13. PubMed ID: 7923205 [Abstract] [Full Text] [Related]
17. Growth inhibition and apoptosis induced by daunomycin-conjugated triplex-forming oligonucleotides targeting the c-myc gene in prostate cancer cells. Napoli S, Negri U, Arcamone F, Capobianco ML, Carbone GM, Catapano CV. Nucleic Acids Res; 2006 Nov 01; 34(2):734-44. PubMed ID: 16449206 [Abstract] [Full Text] [Related]
18. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression. Suhasini M, Boss GR, Pascual FE, Pilz RB. Cell Growth Differ; 1995 Dec 01; 6(12):1559-66. PubMed ID: 9019161 [Abstract] [Full Text] [Related]
19. Activity of (7) anthracycline related compounds in an doxorubicin sensitive human small cell lung cancer line and its doxorubicin resistant descendant. Activity of doxorubicin, daunorubicin, 4-deoxyrubicin, 4-demethoxydaunorubicin, detorubicin, 4'-epidoxorubicin and mitoxantrone. Zijlstra JG, Meijer C, Timmer-Bosscha H, Le TK, de Vries EG, Mulder NH. Eur J Respir Dis Suppl; 1987 Dec 01; 149():53-5. PubMed ID: 3034649 [No Abstract] [Full Text] [Related]
20. Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor alpha and c-Myc. Dadiani M, Seger D, Kreizman T, Badikhi D, Margalit R, Eilam R, Degani H. Endocr Relat Cancer; 2009 Sep 01; 16(3):819-34. PubMed ID: 19398483 [Abstract] [Full Text] [Related] Page: [Next] [New Search]